These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 17699375

  • 1. The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease?
    Kalantar-Zadeh K, Kalantar-Zadeh K, Lee GH.
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S9-18. PubMed ID: 17699375
    [Abstract] [Full Text] [Related]

  • 2. Should we limit the ferritin upper threshold to 500 ng/ml in CKD patients?
    Dukkipati R, Kalantar-Zadeh K.
    Nephrol News Issues; 2007 Jan; 21(1):34-8. PubMed ID: 17269263
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Monitoring iron status in end-stage renal disease patients on hemodialysis.
    Rafi A, Karkar A, Abdelrahman M.
    Saudi J Kidney Dis Transpl; 2007 Mar; 18(1):73-8. PubMed ID: 17237895
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Iron and clinical outcomes in dialysis and non-dialysis-dependent chronic kidney disease patients.
    Kovesdy CP.
    Adv Chronic Kidney Dis; 2009 Mar; 16(2):109-16. PubMed ID: 19233070
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comprehensive vision for intravenous iron therapy.
    Coyne DW.
    Am J Kidney Dis; 2008 Dec; 52(6 Suppl):S14-20. PubMed ID: 19010257
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [How do we optimally evaluate iron stores in dialyzed patients treated with erythropoiesis stimulating agent?].
    Kessler M, Salignac S, Aimone-Gastin I.
    Nephrol Ther; 2006 Sep; 2 Suppl 4():S261-5. PubMed ID: 17373268
    [Abstract] [Full Text] [Related]

  • 15. Iron therapy in chronic kidney disease: current controversies.
    Kovesdy CP, Kalantar-Zadeh K.
    J Ren Care; 2009 Dec; 35 Suppl 2():14-24. PubMed ID: 19891681
    [Abstract] [Full Text] [Related]

  • 16. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004.
    Fishbane S, Pollack S, Feldman HI, Joffe MM.
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):57-61. PubMed ID: 18987297
    [Abstract] [Full Text] [Related]

  • 17. Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients.
    Rocha LA, Barreto DV, Barreto FC, Dias CB, Moysés R, Silva MR, Moura LA, Draibe SA, Jorgetti V, Carvalho AB, Canziani ME.
    Clin J Am Soc Nephrol; 2009 Jan; 4(1):105-9. PubMed ID: 18842949
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Importance of ferritin for optimizing anemia therapy in chronic kidney disease.
    Nakanishi T, Kuragano T, Nanami M, Otaki Y, Nonoguchi H, Hasuike Y.
    Am J Nephrol; 2010 Jan; 32(5):439-46. PubMed ID: 20881381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.